glp-1 glp-2 dual agonist receptor agonists Science Behind GLP 1 GIP

Yes, due to its glycemic and weight loss effects, oral semaglutide (Rybelsus) is a great option for patients with Type 2 diabetes who would also benet from weight loss, says Dr

[DOI] [PubMed] [Google Scholar] 61.Buteau J, Foisy S, Rhodes CJ, et al

Horm Metab Res (2021) 53(6):4027

J Gen Intern Med

That said, these effects are not yet well established clinically, and more research is needed to determine whether they are directly caused by the medication or influenced by factors such as weight loss, metabolic changes, or individual physiology

Multiple sclerosis patients taking glucagon-like peptide-1 receptor (GLP-1) agonists: a single-institution retrospective cohort study of tolerability and weight loss